Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed Nov 12, 2025 · 10-Q · 43 days after period end · 0001437749-25-034427
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Net Income | -$10.81M | -$27.94M | -$25.65M | -$20.26M |
| EPS Diluted | -$0.22 | -$0.58 | -$0.61 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Sep 30, 2025 · filed Nov 12, 2025 · 43 d after period end
